Publication | Open Access

Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment

NanomedicineTumor ImmunologySunitinib Base EnhancesMelanomaImmunologyTherapeutic VaccineImmune Checkpoint InhibitorTumor TargetingImmunotherapyMedicineCell BiologyAdvanced MelanomaTumor MicroenvironmentTumor-targeted Delivery